टाइम फर्मास्युटिकल्सको आईपीओ मूल्य ४५० रुपैयाँ कायम, सर्वसाधारणका लागि निष्कासनको तयारीTime Pharmaceuticals Sets IPO Price at Rs. 450 After Completing Book Building Process

Kathmandu — Time Pharmaceuticals Limited, which is preparing to issue its Initial Public Offering (IPO) through the book building method, has completed the bidding process for qualified institutional investors. The company has fixed the cut-off price of its shares at Rs. 500 per share following the institutional bidding process.

Under the existing book building regulations, general investors will receive a 10 percent discount on the cut-off price. As a result, the company’s IPO will be available to the public at Rs. 450 per share.

The pharmaceutical company plans to issue 1.0865 million ordinary shares, equivalent to 20.50 percent of its issued capital of Rs. 530 million.

Of the total shares to be issued, 40 percent or 434,600 shares have already been allocated to qualified institutional investors through the book building process.

The remaining 60 percent or 651,900 shares have been reserved for general investors. Investors participating in the IPO through the book building method will be required to apply for a minimum of 50 shares, according to the company.

With the institutional bidding process successfully completed, Time Pharmaceuticals will now apply to the Securities Board of Nepal (SEBON) for approval to issue shares to the general public.

After receiving regulatory approval, the company will announce the IPO issuance date.

The completion of the book building process marks an important step toward the company’s public listing. The method allows share prices to be determined based on institutional investors’ valuation and market demand rather than a fixed pricing mechanism, making it different from the traditional IPO pricing system.